Percheron Therapeutics Discontinues American Depository Receipt Facility, Uplists to OTCQB

MT Newswires Live

Dec 03, 2024

Percheron Therapeutics (ASX:PER) has ended its American Depository Receipt (ADR) facility with financial services provider BNY Mellon, according to a Tuesday filing with the Australian bourse.

The ADR, trading with the ticker 'ATHJY' will no longer be quoted via over-the-counter (OTC) markets, the filing said.

The biotechnology company has now uplisted its foreign shares (F shares), trading with the ticker 'ATHJF', to the Over-the-Counter Bulletin Board (OTCQB) tier of the OTC markets.

The company has applied to the US Financial Industry Regulatory Authority for sponsorship of its F shares and a ticker change from 'ATHJF' to 'PERCF.'

These moves are expected to improve access to the company's securities to US investors and reduce costs for the company.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/2488965212"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2488965212\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2488965212?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-12-03 15:00","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2488965212","market":"us","top_or_hot":-1,"title":"Percheron Therapeutics Discontinues American Depository Receipt Facility, Uplists to OTCQB","media":"MT Newswires Live","content":"<html><body><p> Percheron <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> (ASX:PER) has ended its American Depository Receipt (ADR) facility with financial services provider BNY Mellon, according to a Tuesday filing with the Australian bourse.</p><p>The ADR, trading with the ticker 'ATHJY' will no longer be quoted via over-the-counter (OTC) markets, the filing said.</p><p>The biotechnology company has now uplisted its foreign shares (F shares), trading with the ticker 'ATHJF', to the Over-the-Counter Bulletin Board (OTCQB) tier of the OTC markets.</p><p>The company has applied to the US Financial Industry Regulatory Authority for sponsorship of its F shares and a ticker change from 'ATHJF' to 'PERCF.'</p><p>These moves are expected to improve access to the company's securities to US investors and reduce costs for the company.</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Percheron Therapeutics Discontinues American Depository Receipt Facility, Uplists to OTCQB</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPercheron Therapeutics Discontinues American Depository Receipt Facility, Uplists to OTCQB\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2024-12-03 15:00</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Percheron <a href=\"https://laohu8.com/S/LENZ\">Therapeutics</a> (ASX:PER) has ended its American Depository Receipt (ADR) facility with financial services provider BNY Mellon, according to a Tuesday filing with the Australian bourse.</p><p>The ADR, trading with the ticker 'ATHJY' will no longer be quoted via over-the-counter (OTC) markets, the filing said.</p><p>The biotechnology company has now uplisted its foreign shares (F shares), trading with the ticker 'ATHJF', to the Over-the-Counter Bulletin Board (OTCQB) tier of the OTC markets.</p><p>The company has applied to the US Financial Industry Regulatory Authority for sponsorship of its F shares and a ticker change from 'ATHJF' to 'PERCF.'</p><p>These moves are expected to improve access to the company's securities to US investors and reduce costs for the company.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"AFG","symbol_name":"美国金融集团有限公司","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2488965212","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2488965212","pubTimestamp":1733209251,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Percheron Therapeutics  has ended its American Depository Receipt  facility with financial services provider BNY Mellon, according to a Tuesday filing with the Australian bourse.The ADR, trading with the ticker 'ATHJY' will no longer be quoted via over-the-counter  markets, the filing said.The biotechnology company has now uplisted its foreign shares , trading with the ticker 'ATHJF', to the Over-the-Counter Bulletin Board  tier of the OTC markets.The company has applied to the US Financial Industry Regulatory Authority for sponsorship of its F shares and a ticker change from 'ATHJF' to 'PERCF.'These moves are expected to improve access to the company's securities to US investors and reduce costs for the company.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"AFG":"美国金融集团有限公司","BK4107":"财产与意外伤害保险","BK7094":"医疗保健技术","BK7096":"制药","BK4117":"多元化保险","PER.AU":"PERCHERON FPO","LENZ":"Therapeutics","ADR.AU":"Adherium Ltd","BK4139":"生物科技"},"translate_title":"Percheron Therapeutics停止美国存托凭证融资，并将其列入OTCQB","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"PER.AU":0.9,"AFG":1,"ADR.AU":1,"LENZ":1},"content_text":"Percheron Therapeutics (ASX:PER) has ended its American Depository Receipt (ADR) facility with financial services provider BNY Mellon, according to a Tuesday filing with the Australian bourse.The ADR, trading with the ticker 'ATHJY' will no longer be quoted via over-the-counter (OTC) markets, the filing said.The biotechnology company has now uplisted its foreign shares (F shares), trading with the ticker 'ATHJF', to the Over-the-Counter Bulletin Board (OTCQB) tier of the OTC markets.The company has applied to the US Financial Industry Regulatory Authority for sponsorship of its F shares and a ticker change from 'ATHJF' to 'PERCF.'These moves are expected to improve access to the company's securities to US investors and reduce costs for the company.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}